Premium
Proteome studies of human cerebrospinal fluid and brain tissue using a preparative two‐dimensional electophoresis approach prior to mass spectrometry
Author(s) -
Davidsson Pia,
Paulson Linda,
Hesse Camilla,
Blennow Kaj,
Nilsson Carol L.
Publication year - 2001
Publication title -
proteomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.26
H-Index - 167
eISSN - 1615-9861
pISSN - 1615-9853
DOI - 10.1002/1615-9861(200103)1:3<444::aid-prot444>3.0.co;2-q
Subject(s) - proteome , proteomics , membrane protein , isoelectric focusing , chemistry , integral membrane protein , biochemistry , two dimensional gel electrophoresis , human brain , gel electrophoresis , isoelectric point , biology , microbiology and biotechnology , membrane , enzyme , neuroscience , gene
A preparative proteomic approach, involving liquid phase isoelectric focusing (IEF) in combination with one‐dimensional electrophoresis and electroelution followed by mass spectrometry and database searches, was found to be an important tool for identifying low‐abundant proteins (μg/L) in human cerebrospinal fluid (CSF) and membrane proteins in human frontal cortex. Several neuron‐related proteins, such as amyloid precursor‐like protein, chromogranins A and B, glial fibrillary acid protein, β‐trace, transthyretin, ubiquitin, and cystatin C, were identified in CSF. Several types of proteins were also characterized from a detergent‐solubilized human frontal cortex homogenate including membrane proteins such as synaptophysin, syntaxin and Na + /K + ATPase. One‐third of the identified proteins have not previously been identified in human CSF or human frontal cortex using proteomic techniques. The absence of these proteins in two‐dimensional electrophoresis maps might be due to insufficient amounts or low solubility. The advantages of using preparative liquid phase electrophoretic separations for identifying proteins from complex biological mixtures are speed of analysis, high loadability in the IEF separation, nondiscrimination of membrane proteins or low abundance proteins, yielding sufficient amounts for characterization by mass spectrometry. The use of this strategy in proteome studies of CSF/brain tissue is expected to offer new perspectives in studies of the pathology of neurodegenerative diseases, and reveal new potential markers for brain disorders.